Decosas Josef, Koama Jean-Baptiste T
Plan International, Accra, Ghana.
Lancet Infect Dis. 2002 Dec;2(12):763-5. doi: 10.1016/s1473-3099(02)00455-3.
Burkina Faso lies within the African meningitis belt. Until recently, serogroup A of Neisseria meningitidis was the most common cause of epidemic meningitis in Burkina Faso. However, during the epidemic that started in January 2002, W135 was the predominant serogroup of meningococcus. Vaccine against the W135 serogroup is expensive and in short supply. Strategies to react to a future African epidemic of W135 meningococcal meningitis with a sufficient and affordable supply of vaccine must be put into place now.
布基纳法索位于非洲脑膜炎带内。直到最近,脑膜炎奈瑟菌A群仍是布基纳法索流行性脑膜炎最常见的病因。然而,在2002年1月开始的疫情期间,W135是脑膜炎球菌的主要血清群。针对W135血清群的疫苗价格昂贵且供应短缺。现在必须制定战略,以便在未来非洲发生W135型脑膜炎球菌性脑膜炎疫情时,能够有足够且价格合理的疫苗供应。